Drug Approval | October 20, 2021
FDA approves Cyltezo, the first interchangeable biosimilar to Humira
Second interchangeable biosimilar product approved by agency
Second interchangeable biosimilar product approved by agency
ICICI Direct gives an update on the 12 companies that it has covered in the healthcare universe. A report
Its store network grew from 144 stores in March 2019 to 236 stores. It has a presence in 23 cities across Maharashtra, Goa and Karnataka, employing more than 4,600 people.
TCS to help Apoteket drive its digital transformation across sales channels and internal processes
Since its inception, over three million users have used MFine services with the platform clocking over three lakh monthly transactions
The company plans to launch its exclusive e-pharmacy and telemedicine services in India by December 2021
The consultations are virtual and they have launched the Diabetes Reversal Programme to address the issue
Over 61 per cent of pharmacists stated that they aim to improve their knowledge and medical skills while 76 per cent collaborated with healthcare players to improve the outcome for their patients
Implementation of the system to provide faster, seamless and hassle-free healthcare solutions
Nat-Lenalidomide, a generic alternative to Revlimid, expands affordable treatment options for patients with multiple myeloma and patients with transfusion-dependent anaemia due to myelodysplastic syndromes (MDS)
Subscribe To Our Newsletter & Stay Updated
